NEW YORK (GenomeWeb News) – Agilent Technologies, a University of Rouen laboratory, and the Bioprocessing Technology Institute in Singapore have signed a memorandum of understanding for the development of tools to analyze biologics and vaccines.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.